Skip to content
          • Log In
      Drug Discovery World (DDW)Drug Discovery World (DDW)
        • About Us
        • Subscribe Free
        • Media Info
        • Contact Us
          Drug Discovery World (DDW) Menu   ≡ ╳
          • Home
          • News
          • Exclusive Content
            • Features
            • Opinion
            • Market Reports
            • Trends & Analysis
            • Start-up Zone
          • DDW eBooks & eReports
          • Cancer Research
          • Business
          • Regulatory
          • Events
          • Webinars
          • Resources
          • Archive
            • –
              • 2000 Archive
              • 2001 Archive
              • 2002 Archive
              • 2003 Archive
              • 2004 Archive
              • 2005 Archive
              • 2006 Archive
            • –
              • 2007 Archive
              • 2008 Archive
              • 2009 Archive
              • 2010 Archive
              • 2011 Archive
              • 2012 Archive
              • 2013 Archive
            • –
              • 2014 Archive
              • 2015 Archive
              • 2016 Archive
              • 2017 Archive
              • 2018 Archive
              • 2019 Archive
          • Multimedia
            • Videos
            • Podcasts

        • Sidebar Banner 6

        • Sidebar Banner 7

        • Sidebar Banner 8

        • Sidebar Banner 12

        • Sidebar Banner 18

        • Sidebar Banner 19

        • Sidebar Banner 20

        • Sidebar Banner 21

        Antibody Fragments

        Eye

        Antibody fragment-based drug could slow geographic atrophy

        4 August 2023

        CDR-Life has reached a development milestone with its antibody fragment-based drug candidate that could significantly slow down the progression of geographic atrophy (GA). Boehringer Ingelheim and CDR-Life entered a collaboration and licensing agreement in May 2020 and announced the selection of an antibody fragment-based therapeutic candidate in September 2021. GA is a progressive, irreversible retinal […]

        Laboratory research

        App note: recombinant antibody formats, expressions & applications

        1 June 2022

        Advancements in antibody engineering technologies have greatly enhanced the generation of recombinant antibodies in various formats as therapeutic agents. There are already more than 100 antibody-based drugs approved by the FDA, and numerous antibodies are currently in their late-stage clinical studies. Compared to monoclonal antibodies produced using traditional hybridoma techniques, recombinant antibodies offer advantages, such […]

        Sidebar Banner 1

        Sidebar Banner 2

        Sidebar Banner 3

        Sidebar Banner 4

        Sidebar Banner 9

        Sidebar Banner 10

        Sidebar Banner 11

        Sidebar Banner 13

        Sidebar Banner 14

        Sidebar Banner 15

        Sidebar Banner 16

        Sidebar Banner 17

          • Contact Us
          • About Us
          • Subscribe FREE
          • Media Info
          • Log In
          • Terms and Conditions
          • Privacy Policy
          • Cookie Policy

        Follow our social accounts

             

        Copyright 2023 © Drug Discovery World (DDW). All Rights Reserved

        Designed & Developed with ❤ for digital by Inbound FinTech

        • Home
        • News
        • Exclusive Content
          • Features
          • Market Reports
          • Opinion
          • Trends & Analysis
          • Start-up Zone
        • DDW eBooks & eReports
        • Cancer Research
        • Business
        • Regulatory
        • Events
        • Webinars
        • Resources
        • Archive
        • Multimedia
          • Podcasts
          • Videos
        • About Us
        • Subscribe Free
        • Media Info
        • Contact Us
            • Log In